Seller record · biolongevitylabs.com

BioLongevity Labs

Recorded September 2026 · Standard v1.1

Fails 3 of 8 criteria. S1, prescriber requirement: No clinician evaluation is required to buy, and although the about page names a physician on its team, the products are sold for research use only. 2 more criteria also fail; see the table below.

Research vendor. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A research peptide seller operating from an Ohio address, offering vials, bioregulators and capsules. Its footer names one operating company and its contact page names the same company under a different corporate form, and the two are reconciled on no page read.

Operating entity F2 Nutrition LLC

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	FAIL	biolongevitylabs.com/ruo-policy
S2	Prescription gating	FAIL	biolongevitylabs.com/cart
S3	Pharmacy identification	FAIL	biolongevitylabs.com/about-us
S4	Compounding disclosure	PASS	biolongevitylabs.com/about-us
S5	Analytical documentation	PASS	biolongevitylabs.com/all-coas
S6	Business address	PASS	biolongevitylabs.com/contact-us
S7	Price disclosure	PASS	biolongevitylabs.com/product/bpc-157-tb-500-cartalax-blend-30mg-10mg-10mg-10mg
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1FAILNo clinician evaluation is required to buy, and although the about page names a physician on its team, the products are sold for research use only.Source: biolongevitylabs.com/ruo-policy.

S2FAILThe order path was walked from the BPC-157 blend page and the cart asked only whether the buyer is over twenty one, with no medical question and no eligibility step.Source: biolongevitylabs.com/cart.

S3FAILNo pharmacy is named on any of the seven pages read, and a footer notice states that the seller is not a compounding pharmacy under section 503A.Source: biolongevitylabs.com/about-us.

S4PASSThe seller offers no compounded drug, and a footer notice on every page read states that its statements have not been evaluated by the Food and Drug Administration.Source: biolongevitylabs.com/about-us.

S5PASSA public certificate library opens with no login. One certificate from BioRegen reports 99.98 percent purity on N-Acetyl Semax Amidate against a specification above 98 percent by mass spectrometry with ultraviolet detection, and its own batch field is blank.Source: biolongevitylabs.com/all-coas.

S6PASSA footer on every page read prints a street address with a unit number on Rothrock Road in Akron, Ohio, and the contact page repeats it.Source: biolongevitylabs.com/contact-us.

S7PASSThe BPC-157 blend page prints 279.97 dollars with no account required, and the catalog prints figures from 19.97 dollars upward.Source: biolongevitylabs.com/product/bpc-157-tb-500-cartalax-blend-30mg-10mg-10mg-10mg.

S8PASSNo letter names either company in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides including BPC-157, TB-500 and semax, peptide blends, bioregulator vials and capsules, metformin capsules, research compounds.

Sellers passing S1, prescriber requirement

Records dated September 2026

Records dated August 2026

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.